Get started
Author

Kori Holman

Observed name: K. Holman
ORCID: 0009-0008-5401-3268
Observed ORCID: 0009-0008-5401-3268
OpenAlex ID: A5017039675
The efficacy and cost-impact of rasburicase 3 mg versus 6 mg for the management of tumor lysis syndrome: A multicenter analysis
2022 · Dennis Marjoncu, Kori Holman · Journal of Oncology Pharmacy Practice · 8
Fresh Versus Cryopreserved Peripheral Stem Cell for Autologous Transplantation in Multiple Myeloma: An Analysis of Short-Term Outcomes
2020 · Jacinth Joseph, Vanessa Wookey, et al. · Blood · 5
Outcomes of Concurrent Radiotherapy With Tarlatamab in Extensive-Stage Small Cell Lung Cancer From the DLL3 PanTUMOR Database
2026 · Diana Kim, Sarah Blocker, et al. · Clinical Lung Cancer · 4
Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practice
2026 · Sarah Blocker, Diana Kim, et al. · European Journal of Cancer · 3
Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review
2026 · Drew A. Wells, Zachery Halford, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2
Evaluation of atezolizumab, durvalumab, lurbinectedin, and tarlatamab in high-grade extrapulmonary neuroendocrine carcinoma: A multicenter retrospective comparative analysis.
2026 · Ty Michael Moore, Courtney C. Cavalieri, et al. · Journal of Clinical Oncology · 1
PDF
The impact of bleomycin test doses on the development of acute hypersensitivity reactions
2025 · Dennis Marjoncu, Kori Holman · Supportive Care in Cancer · 1
PDF
Use of antithymocyte globulin (rabbit) in a patient with known alpha-gal syndrome undergoing allogenic stem cell transplantation
2023 · Hannah Peterson, Drew A Wells, et al. · Journal of Oncology Pharmacy Practice · 1
233 A real-world case of second chimeric antigen receptor t-cell therapy
2022 · Jacinth Joseph, Dennis Marjoncu, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Analysis of corticosteroid exposure on efficacy of tarlatamab in small cell lung cancer: A multicenter retrospective study.
2026 · Ty Michael Moore, Courtney C. Cavalieri, et al. · Journal of Clinical Oncology
Corrigendum to “Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practice” [Eur. J. Cancer 238 (May) (2026) 116686]
2026 · Sarah Blocker, Diana Kim, et al. · European Journal of Cancer
PDF
929: Effect of N-acetylcysteine on Early Allograft Dysfunction in Liver Transplant Recipients
2026 · Natalie Greer, Courtney Overton, et al. · Critical Care Medicine
174P Efficacy outcomes and risk factors for CRS and ICANS with tarlatamab in small cell lung cancer: Insights from clinical practice
2025 · J. Zhang, S. Blocker, et al. · Immuno-Oncology Technology
Works count: 13
Citation count: 26
H-index: 3
I10-index:
Year
Topic
Type